Byrna Technologies Inc., a less-lethal self-defense technology company, develops, manufactures, and sells less-lethal personal security solutions in the United States, South Africa, Europe, South America, Asia, and Canada. The company offers handheld personal security devices and shoulder-fired launchers designed for use by consumers and professional security customers without the need for a background check or firearms license; projectiles, such as chemical irritant, kinetic, and inert rounds; self-defense aerosol products comprising Byrna Bad Guy Repellent; and accessories and related safety products, such as Byrna Banshee, Byrna Shield, compressed carbon dioxide canisters, sighting systems, holsters, and Byrna-branded apparel. It sells its products to the consumer market through its Byrna e-commerce store and Amazon storefront, Side Hustle dealer program, premier dealers, and a network of outdoor and sporting goods stores either directly or through distributors; and to the professional security market through Train the trainer program. The company was formerly known as Security Devices International, Inc. and changed its name to Byrna Technologies Inc. in March 2020. Byrna Technologies Inc. was incorporated in 2005 and is headquartered in Andover, Massachusetts.…
Is It Too Early To Buy Axon Enterprise Stock?
BYRN Q3 Deep Dive: Margin Improvements and Marketing Initiatives Offset Revenue Decline
Byrna Technologies (NASDAQ: BYRN) is listed on Nasdaq, where its shares trade in USD. It belongs to the Aerospace & Defense industry, part of the Industrials sector, and reports about 159 employees.
The shares were at 3.060 USD on 20 November 2026, down 83.4% over 52 weeks. Its 52-week range is 3.040 USD to 20.69 USD, and it trades at the bottom of that range.
Its market capitalisation is 71.62M USD.
Byrna Technologies reports return on equity of 14.7%, an operating margin of -11.4% and revenue down 45.7% year over year.
It holds more cash than debt, a net cash position of 8.18M USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 6.333 USD is 107.0% above the current price. The next earnings report is expected on 4 February 2027.